Literature DB >> 26282574

Pulmonary arterial hypertension in a child with stage-IV neuroblastoma after autologous hematopoietic stem cell transplantation and review of the literature.

Derya Özyörük1, Ayşe Esin Kibar2, Murat Sürücü2, Emine Azak2, Suna Emir1, İbrahim İlker Çetin2, Bahattin Tunç3, Namık Yaşar Özbek3.   

Abstract

PH is a rare condition with high mortality rate after pediatric HSCT. As clinical presentation is non-specific and may mimic other conditions, a high degree of suspicion is required for diagnosis. Here, we present a patient with stage-IV neuroblastoma who developed PAH after autologous HSCT. After exclusion of other causes of PH, we regarded that this condition was secondary to HSCT.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  children; hematopoietic stem cell transplantation; pulmonary hypertension

Mesh:

Year:  2015        PMID: 26282574     DOI: 10.1111/petr.12576

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  2 in total

1.  Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma.

Authors:  A V Desai; M B Heneghan; Y Li; N J Bunin; S A Grupp; R Bagatell; A E Seif
Journal:  Bone Marrow Transplant       Date:  2016-05-09       Impact factor: 5.483

Review 2.  Hematological disorders and pulmonary hypertension.

Authors:  Rajamma Mathew; Jing Huang; Joseph M Wu; John T Fallon; Michael H Gewitz
Journal:  World J Cardiol       Date:  2016-12-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.